Article
Generation of CRISPR/Cas9-edited human iPSC lines carrying homozygous and heterozygous SAMD9 p.I983S mutations.
Stem cell research - 1 Dec 2024
Khiami Majd, Ju Yan, Han Lei, Klein Jonathan, Han Min-Joon, Pruett-Miller Shondra M, Wlodarski Marcin W
Abstract excerpt
Induced pluripotent stem cells (iPSCs) harboring patient derived SAMD9 mutation offer a unique platform to study the multi-organ involvement observed in this rare disease, referred to as myelodysplasia, infections, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy (MIRAGE) syndrome. The pluripotent nature of iPSCs allows in vitro differentiation into various somatic cell types...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
